-       Report 
- March 2025
-  144 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- October 2025
-  198 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  194 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
           -       Report 
- February 2024
-  119 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- July 2024
-  82 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
             Nuclear Medicine Radioisotopes are used in Oncology Drugs to diagnose and treat cancer. Radioisotopes are injected into the body and emit radiation that can be detected by imaging devices. This radiation helps to identify cancerous cells and can be used to target and destroy them. Radioisotopes can also be used to measure the effectiveness of cancer treatments.
Nuclear Medicine Radioisotopes are used in a variety of Oncology Drugs, including chemotherapy, radiotherapy, and immunotherapy. They are    also used in combination with other treatments, such as surgery and hormone therapy.
Nuclear Medicine Radioisotopes are produced by a number of companies, including GE Healthcare, Mallinckrodt Pharmaceuticals, and Nordion. These companies specialize in the production and distribution of radioisotopes for medical use. Show Less   Read more